Tim Karl

6.4k total citations
127 papers, 5.0k citations indexed

About

Tim Karl is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Tim Karl has authored 127 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Cellular and Molecular Neuroscience, 42 papers in Molecular Biology and 38 papers in Pharmacology. Recurrent topics in Tim Karl's work include Cannabis and Cannabinoid Research (30 papers), Neurotransmitter Receptor Influence on Behavior (25 papers) and Neuroscience and Neuropharmacology Research (25 papers). Tim Karl is often cited by papers focused on Cannabis and Cannabinoid Research (30 papers), Neurotransmitter Receptor Influence on Behavior (25 papers) and Neuroscience and Neuropharmacology Research (25 papers). Tim Karl collaborates with scholars based in Australia, Germany and United States. Tim Karl's co-authors include Brett Garner, Jonathon C. Arnold, Stephan von Hörsten, Herbert Herzog, Liesl Duffy, Rose Chesworth, David Cheng, Georgia Watt, Reinhard Pabst and Xu‐Feng Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Neuroscience.

In The Last Decade

Tim Karl

123 papers receiving 4.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tim Karl Australia	42	2.1k	1.6k	1.3k	985	506	127	5.0k
Elizabeth A. Thomas United States	46	2.0k 0.9×	803 0.5×	3.0k 2.3×	1.2k 1.2×	357 0.7×	129	5.9k
Atsumi Nitta Japan	46	2.8k 1.3×	927 0.6×	2.2k 1.6×	1.5k 1.6×	697 1.4×	181	6.4k
Gerhard Rammes Germany	40	3.8k 1.8×	2.3k 1.5×	1.8k 1.4×	1.3k 1.3×	576 1.1×	133	7.3k
Bruno P. Guiard France	36	2.7k 1.3×	858 0.6×	1.8k 1.3×	834 0.8×	1.1k 2.1×	97	5.5k
Alessandro Usiello Italy	49	3.8k 1.8×	894 0.6×	3.2k 2.4×	889 0.9×	536 1.1×	145	7.3k
Mariaelvina Sala Italy	44	2.4k 1.1×	1.5k 1.0×	1.7k 1.3×	593 0.6×	192 0.4×	124	5.3k
Bruce Ladenheim United States	41	2.9k 1.4×	445 0.3×	2.1k 1.6×	656 0.7×	448 0.9×	97	5.2k
Nicholas M. Barnes United Kingdom	42	4.0k 1.9×	761 0.5×	3.3k 2.5×	833 0.8×	867 1.7×	147	7.7k
Carmen Guaza Spain	54	2.9k 1.3×	4.0k 2.6×	1.8k 1.4×	1.0k 1.0×	1.1k 2.1×	160	8.5k
Yukihiro Noda Japan	52	4.1k 1.9×	762 0.5×	3.3k 2.5×	1.4k 1.4×	930 1.8×	238	7.9k

Countries citing papers authored by Tim Karl

Since Specialization

Citations

This map shows the geographic impact of Tim Karl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Karl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Karl more than expected).

Fields of papers citing papers by Tim Karl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Karl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Karl. The network helps show where Tim Karl may publish in the future.

Co-authorship network of co-authors of Tim Karl

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Karl. A scholar is included among the top collaborators of Tim Karl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Karl. Tim Karl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chu‐Tan, Joshua A., Yvette Wooff, Tim Karl, et al.. (2023). Voluntary exercise modulates pathways associated with amelioration of retinal degenerative diseases. Frontiers in Physiology. 14. 1116898–1116898. 3 indexed citations

Niedermayer, Garry, et al.. (2023). Chronic interleukin-6 mediated neuroinflammation decreases anxiety, and impaires spatial memory in aged female mice. Frontiers in Neuroscience. 17. 1267818–1267818. 2 indexed citations

Deng, Liting, Vivek Gupta, Yunqi Wu, et al.. (2021). Mouse model of Alzheimer's disease demonstrates differential effects of early disease pathology on various brain regions. PROTEOMICS. 21(7-8). e2000213–e2000213. 8 indexed citations

Sinclair, Duncan, Terri Sebree, Marcel O. Bonn‐Miller, et al.. (2019). Cannabidiol (CBD) reduces anxiety-related behavior in mice via an FMRP-independent mechanism. Pharmacology Biochemistry and Behavior. 181. 93–100. 44 indexed citations

Mirzaei, Mehdi, Liting Deng, Nitin Chitranshi, et al.. (2019). Upregulation of Proteolytic Pathways and Altered Protein Biosynthesis Underlie Retinal Pathology in a Mouse Model of Alzheimer’s Disease. Molecular Neurobiology. 56(9). 6017–6034. 46 indexed citations

Gyengési, Erika, Alejandra Rangel, Faheem Ullah, et al.. (2019). Chronic Microglial Activation in the GFAP-IL6 Mouse Contributes to Age-Dependent Cerebellar Volume Loss and Impairment in Motor Function. Frontiers in Neuroscience. 13. 303–303. 50 indexed citations

Lloyd, David B., David A. Talmage, Cynthia Shannon Weickert, & Tim Karl. (2018). Reduced type III neuregulin 1 expression does not modulate the behavioural sensitivity of mice to acute Δ 9 -tetrahydrocannabinol (D 9 -THC). Pharmacology Biochemistry and Behavior. 170. 64–70. 5 indexed citations

Low, Jac Kee, Louise Purtell, Yue Qi, et al.. (2015). Behavioural characteristics of the Prader–Willi syndrome related biallelic Snord116 mouse model. Deakin Research Online (Deakin University). 3 indexed citations

Low, Jac Kee, Louise Purtell, Yue Qi, et al.. (2015). Behavioural characteristics of the Prader–Willi syndrome related biallelic Snord116 mouse model. Neuropeptides. 53. 71–77. 20 indexed citations

10.

Spencer, Jarrah R., Aurélie A. Boucher, Mohammed A. Kashem, et al.. (2013). Novel molecular changes induced by Nrg1 hypomorphism and Nrg1-cannabinoid interaction in adolescence: a hippocampal proteomic study in mice. Frontiers in Cellular Neuroscience. 7. 15–15. 29 indexed citations

11.

Kim, Woojin S., Hongyun Li, Kalani Ruberu, et al.. (2013). Deletion ofAbca7Increases Cerebral Amyloid-β Accumulation in the J20 Mouse Model of Alzheimer's Disease. Journal of Neuroscience. 33(10). 4387–4394. 155 indexed citations

12.

Logge, Warren, J G Kingham, & Tim Karl. (2013). Behavioural consequences of IVC cages on male and female C57BL/6J mice. Neuroscience. 237. 285–293. 30 indexed citations

13.

Karl, Tim, David Cheng, Brett Garner, & Jonathon C. Arnold. (2012). The therapeutic potential of the endocannabinoid system for Alzheimer's disease. Expert Opinion on Therapeutic Targets. 16(4). 407–420. 35 indexed citations

14.

Chesworth, Rose, Laura Downey, Warren Logge, Simon Killcross, & Tim Karl. (2011). Cognition in female transmembrane domain neuregulin 1 mutant mice. Behavioural Brain Research. 226(1). 218–223. 43 indexed citations

15.

Boucher, Aurélie A., Glenn E. Hunt, Jacques Micheau, et al.. (2010). The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids. The International Journal of Neuropsychopharmacology. 14(5). 631–643. 59 indexed citations

16.

Long, Leonora E., Rose Chesworth, Xu‐Feng Huang, et al.. (2009). A behavioural comparison of acute and chronic Δ9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice. The International Journal of Neuropsychopharmacology. 13(7). 861–876. 163 indexed citations

17.

Duffy, Liesl, et al.. (2008). Behavioral profile of a heterozygous mutant mouse model for EGF-like domain neuregulin 1.. Behavioral Neuroscience. 122(4). 748–759. 48 indexed citations

18.

Karl, Tim, Liesl Duffy, Anna Scimone, Richard P. Harvey, & Peter R. Schofield. (2006). Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia. Genes Brain & Behavior. 6(7). 677–687. 133 indexed citations

19.

Lee, Nicola J., Katy Slack, Tim Karl, et al.. (2006). Distinct endocrine effects of chronic haloperidol or risperidone administration in male rats. Neuropharmacology. 51(7-8). 1129–1136. 29 indexed citations

20.

Karl, Tim, Reinhard Pabst, & Stephan von Hörsten. (2003). Behavioral phenotyping of mice in pharmacological and toxicological research. Experimental and Toxicologic Pathology. 55(1). 69–83. 274 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact